{
  "DOI": "10.1038/s41431-022-01180-0",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01180-0",
  "alternative-id": [
    "1180"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "21 March 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "3 August 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "16 August 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "2 September 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Ethical approval was not required as no individual patient data was used for this article. Data was extracted from other publications and cannot be traced to any individual patient."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-5345-9788",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "van der Pol",
      "given": "Karel H.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-7476-6867",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nijenhuis",
      "given": "Marga",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Soree",
      "given": "Bianca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Boer-Veger",
      "given": "Nienke J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buunk",
      "given": "Anne Marie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Risselada",
      "given": "Arne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Schaik",
      "given": "Ron H. N.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3965-5552",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Swen",
      "given": "Jesse J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Touw",
      "given": "Daan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van der Weide",
      "given": "Jan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2298-9924",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "van Westrhenen",
      "given": "Roos",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Deneer",
      "given": "Vera H. M.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-9927-7266",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Houwink",
      "given": "Elisa J. F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rongen",
      "given": "Gerard A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ],
    "date-time": "2022-09-02T04:02:50Z",
    "timestamp": 1662091370000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        9
      ]
    ],
    "date-time": "2024-02-09T00:11:45Z",
    "timestamp": 1707437505000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        3
      ]
    ],
    "date-time": "2024-04-03T07:47:04Z",
    "timestamp": 1712130424587
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2024,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            2
          ]
        ],
        "date-time": "2022-09-02T00:00:00Z",
        "timestamp": 1662076800000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            2
          ]
        ],
        "date-time": "2022-09-02T00:00:00Z",
        "timestamp": 1662076800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01180-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01180-0",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01180-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "155-162",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2024,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "1180_CR1",
      "unstructured": "Royal Dutch Pharmacists Association (KNMP): Pharmacogenetic Recommendation Text [cited 2022 2nd of January]. Available from: https://www.knmp.nl/."
    },
    {
      "key": "1180_CR2",
      "unstructured": "(EACPT) EAfCPaT. [cited 2022 2nd of January]. Available from: https://www.eacpt.eu/."
    },
    {
      "key": "1180_CR3",
      "unstructured": "(EAHP) EAoHP. [cited 2022 2nd of January]. Available from: https://www.eahp.eu/."
    },
    {
      "DOI": "10.1002/cpt.911",
      "author": "U Amstutz",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "journal-title": "Clin Pharm Ther",
      "key": "1180_CR4",
      "unstructured": "Amstutz U, Henricks LM, Offer SM, Barbarino J, Schellens JHM, Swen JJ, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 Update. Clin Pharm Ther. 2018;103:210–6.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.762",
      "author": "PCD Bank",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Clin Pharm Ther",
      "key": "1180_CR5",
      "unstructured": "Bank PCD, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, et al. Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group. Clin Pharm Ther. 2018;103:599–618.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-019-0540-0",
      "author": "CATC Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Eur J Hum Genet",
      "key": "1180_CR6",
      "unstructured": "Lunenburg CATC, van der Wouden CH, Nijenhuis M, Crommentuijn-van Rhenen MH, de Boer-Veger NJ, Buunk AM, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines. Eur J Hum Genet. 2020;28:508–17.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1038/clpt.2011.34",
      "author": "J Swen",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "journal-title": "Clin Pharmacol Therapeutics",
      "key": "1180_CR7",
      "unstructured": "Swen J, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee A, Mulder H, et al. Pharmacogenetics: From Bench to Byte— An Update of Guidelines. Clin Pharmacol Therapeutics. 2011;89:662–73.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1038/sj.clpt.6100507",
      "author": "J Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharmacol Therapeutics",
      "key": "1180_CR8",
      "unstructured": "Swen J, Wilting I, de Goede A, Grandia L, Mulder H, Touw D, et al. Pharmacogenetics: From Bench to Byte. Clin Pharmacol Therapeutics. 2008;83:781–7.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41431-021-00920-y",
      "doi-asserted-by": "publisher",
      "key": "1180_CR9",
      "unstructured": "Matic M, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk A-M, Houwink EJF, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). Eur J Human Genet. 2021. https://doi.org/10.1038/s41431-021-00920-y. Epub ahead of print."
    },
    {
      "DOI": "10.1038/s41431-021-01004-7",
      "doi-asserted-by": "publisher",
      "key": "1180_CR10",
      "unstructured": "Brouwer J, Nijenhuis M, Soree B, Guchelaar HJ, Swen JJ, van Schaik RHN, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. Eur J Hum Genet. 2021. https://doi.org/10.1038/s41431-021-01004-7. Epub ahead of print."
    },
    {
      "DOI": "10.1111/ijcp.13316",
      "author": "CW Lin",
      "doi-asserted-by": "publisher",
      "first-page": "e13316",
      "journal-title": "Int J Clin Pr",
      "key": "1180_CR11",
      "unstructured": "Lin CW, Huang WI, Chao PH, Chen WW, Hsiao FY. Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real-world patients: A nationwide study. Int J Clin Pr. 2019;73:e13316.",
      "volume": "73",
      "year": "2019"
    },
    {
      "DOI": "10.1038/gim.2014.195",
      "author": "JW Jung",
      "doi-asserted-by": "publisher",
      "first-page": "807",
      "journal-title": "Genet Med",
      "key": "1180_CR12",
      "unstructured": "Jung JW, Kim DK, Park HW, Oh KH, Joo KW, Kim YS, et al. An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing. Genet Med. 2015;17:807–14.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1097/FPC.0000000000000285",
      "author": "N Saksit",
      "doi-asserted-by": "publisher",
      "first-page": "255",
      "journal-title": "Pharmacogenet Genomics",
      "key": "1180_CR13",
      "unstructured": "Saksit N, Tassaneeyakul W, Nakkam N, Konyoung P, Khunarkornsiri U, Chumworathayi P, et al. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Pharmacogenet Genomics. 2017;27:255–63.",
      "volume": "27",
      "year": "2017"
    },
    {
      "author": "SF Keller",
      "first-page": "1187",
      "journal-title": "Ann Rheum Dis",
      "key": "1180_CR14",
      "unstructured": "Keller SF, Lu N, Blumenthal KG, Rai SK, Yokose C, Choi JWJ, et al. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018;77:1187–93.",
      "volume": "77",
      "year": "2018"
    },
    {
      "DOI": "10.2133/dmpk.DMPK-13-RV-119",
      "author": "K Inoue",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "journal-title": "Drug Metab Pharmacokinet",
      "key": "1180_CR15",
      "unstructured": "Inoue K, Yuasa H. Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy. Drug Metab Pharmacokinet. 2014;29:12–9.",
      "volume": "29",
      "year": "2014"
    },
    {
      "DOI": "10.1093/eurheartj/ehl094",
      "author": "RA Kloner",
      "doi-asserted-by": "publisher",
      "first-page": "2400",
      "journal-title": "EurHeart J.",
      "key": "1180_CR16",
      "unstructured": "Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. EurHeart J. 2006;27:2400–5.",
      "volume": "27",
      "year": "2006"
    },
    {
      "key": "1180_CR17",
      "unstructured": "NCBI gene database [Internet]. NCBI: National Center for Biotechnology Information. 2021 [cited 11/08/2021]. Available from: https://www.ncbi.nlm.nih.gov/gene/."
    },
    {
      "DOI": "10.3390/ijms22136678",
      "author": "R Eckenstaler",
      "doi-asserted-by": "publisher",
      "first-page": "6678",
      "journal-title": "Int J Mol Sci",
      "key": "1180_CR18",
      "unstructured": "Eckenstaler R, Benndorf RA. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update. Int J Mol Sci. 2021;22:6678.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.dmpk.2017.11.002",
      "author": "M Nakamura",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Drug Metab Pharmacokinet",
      "key": "1180_CR19",
      "unstructured": "Nakamura M, Fujita K, Toyoda Y, Takada T, Hasegawa H, Ichida K. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2. Drug Metab Pharmacokinet. 2018;33:77–81.",
      "volume": "33",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.apsb.2019.01.007",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "659",
      "journal-title": "Acta Pharm Sin B",
      "key": "1180_CR20",
      "unstructured": "Chen L, Manautou JE, Rasmussen TP, Zhong XB. Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2. Acta Pharm Sin B 2019;9:659–74.",
      "volume": "9",
      "year": "2019"
    },
    {
      "author": "R Li",
      "first-page": "9812",
      "journal-title": "Int J Clin Exp Pathol",
      "key": "1180_CR21",
      "unstructured": "Li R, Miao L, Qin L, Xiang Y, Zhang X, Peng H, et al. A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk. Int J Clin Exp Pathol. 2015;8:9812–23.",
      "volume": "8",
      "year": "2015"
    },
    {
      "key": "1180_CR22",
      "unstructured": "Nucleotide [Internet]: Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; [Available from: https://www.ncbi.nlm.nih.gov/nuccore/EU499350.1."
    },
    {
      "DOI": "10.1038/ng0595-111",
      "author": "P Frosst",
      "doi-asserted-by": "publisher",
      "first-page": "111",
      "journal-title": "Nat Genet",
      "key": "1180_CR23",
      "unstructured": "Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–3.",
      "volume": "10",
      "year": "1995"
    },
    {
      "DOI": "10.1086/301825",
      "author": "NM van der Put",
      "doi-asserted-by": "publisher",
      "first-page": "1044",
      "journal-title": "Am J Hum Genet",
      "key": "1180_CR24",
      "unstructured": "van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044–51.",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1017/S0007114518000508",
      "author": "B Du",
      "doi-asserted-by": "publisher",
      "first-page": "887",
      "journal-title": "Br J Nutr",
      "key": "1180_CR25",
      "unstructured": "Du B, Tian H, Tian D, Zhang C, Wang W, Wang L, et al. Genetic polymorphisms of key enzymes in folate metabolism affect the efficacy of folate therapy in patients with hyperhomocysteinaemia. Br J Nutr. 2018;119:887–95.",
      "volume": "119",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s00296-015-3219-z",
      "author": "T Soukup",
      "doi-asserted-by": "publisher",
      "first-page": "1149",
      "journal-title": "Rheumatol Int",
      "key": "1180_CR26",
      "unstructured": "Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, et al. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients. Rheumatol Int. 2015;35:1149–61.",
      "volume": "35",
      "year": "2015"
    },
    {
      "author": "B Shea",
      "first-page": "Cd000951",
      "journal-title": "Cochrane Database Syst Rev",
      "key": "1180_CR27",
      "unstructured": "Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2013;2013:Cd000951.",
      "volume": "2013",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cpt.1049",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "journal-title": "Clin Pharm Ther",
      "key": "1180_CR28",
      "unstructured": "Swen JJ, Nijenhuis M, van Rhenen M, de Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Pharmacogenetic Information in Clinical Guidelines: The European Perspective. Clin Pharm Ther. 2018;103:795–801.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.161",
      "author": "Y Saito",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Clin Pharm Ther",
      "key": "1180_CR29",
      "unstructured": "Saito Y, Stamp LK, Caudle KE, Hershfield MS, McDonagh EM, Callaghan JT, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharm Ther. 2016;99:36–7.",
      "volume": "99",
      "year": "2016"
    },
    {
      "key": "1180_CR30",
      "unstructured": "Pharmacovigilance Working Party (PhVWP) monthly report on safety concerns, guidelines and general matters - July 2012: Allopurinol: risk of skin reactions associated with HLA-B*5801 allele: European Medicine Agency CFMPFHU, Pharmacovigilance Working Party; 2012 [Available from: https://www.ema.europa.eu/en/monthly-reports-chmp-pharmacovigilance-working-party."
    },
    {
      "DOI": "10.1002/acr.21772",
      "author": "D Khanna",
      "doi-asserted-by": "publisher",
      "first-page": "1431",
      "journal-title": "Arthritis Care Res (Hoboken)",
      "key": "1180_CR31",
      "unstructured": "Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64:1431–46.",
      "volume": "64",
      "year": "2012"
    }
  ],
  "reference-count": 31,
  "references-count": 31,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01180-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "32"
}